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Abstract 
Background: Homelessness happens when people or household are unable to acquire and/or maintain housing they can afford. 
Approximately 17% of homeless individuals are also chronically ill. Studies have often not objectively measured medication non- 
adherence among the homeless population, probably due to lack of consistent pharmacy records. This study proposed to objectively 
estimate medication non-adherence to chronic medications among the homeless population in Salt Lake City, Utah. 
Methods: A retrospective study design was used based on the pharmacy records from the Fourth Street Pharmacy based on four 
classes of chronic medications – asthma, diabetes, statins, and psychiatric medications. Data was collected between November 1, 
2010 and February 28, 2011 on the variables: date of original prescription, number of refills on the original prescription, date of 1st, 
2nd, 3rd, and 4th fills, age, gender, and race. Primary non-adherence and medication refill non-adherence based on Continuous 
Measure of Medication Gaps were calculated. 
Results: The medication refill non-adherence rate was 38.8% with asthma medications, 38.5% with diabetic medications, 27.2% with 
statins, and 47.1% with psychiatric medications. The primary non-adherence rate varied from zero percent to 20%. 
Conclusion: The study concluded that this population has comparable non-adherence rates with asthma, diabetes, cholesterol 




Homelessness is a situation when people or household are 
unable to acquire and/or maintain housing they can afford 
(1). According to the National Alliance to End Homelessness, 
there are around 643,067 people experiencing homelessness 
on any given night in the United States (1). The 2008 US 
Conference of Mayors Study reported that the three primary 
causes of homelessness among families are lack of affordable 
housing, poverty, and unemployment; the major causes of 
homelessness among individuals are substance abuse, lack 
of affordable housing, and mental illness (2). Approximately 
seventeen percent of these homeless individuals are also 
chronically ill (1). Having a chronic disease requires 
medication adherence for the treatment to be successful. 
Medication non-adherence, defined as the extent to which a 
person’s behavior does not coincide with medical or health 
advice, is very common with chronic medications (3, 4). 
Medication non-adherence can lead to poor health 
outcomes, admission to emergency rooms and hospitals, 
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increased physician visits, and overall increase in health care 
costs (5-10). 
Several studies have focused on the health of the homeless, 
their health care utilization and barriers to their use of health 
care (11-15). Previous studies have reported several factors 
that affect medication adherence in homeless adults (16-18). 
Some of the major barriers to adherence among homeless  
are lack of privacy, lack of storage place for medications, and 
stolen/lost medications (16). Disaffiliation, the absence of the 
affiliative bonds that link individuals to a network of 
interconnected social structures, is another major reason for 
medication non-adherence among homeless (19). Whitney 
and Glazier reported the various factors that affect 
medication adherence at various stages of the medication 
taking process including assessing, retaining, and following 
the regimen (18). For accessing medications, financial 
difficulty and social isolation are the major barriers. Not 
having a permanent place to stay and stolen medications 
were the main reasons for not being able to retain the 
medications. For not following the regimen, the main barriers 
were alcohol and drug dependency, inability to follow 
instructions, mental illness, and lifestyle factors. 
 
Past studies on medication non-adherence among the 
homeless often focused on populations taking HIV 
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medications (20-22). The other chronic condition that was 
studied was psychiatric conditions. However, for psychiatric 
medications, the studies were focused on the reasons for 
non-adherence and interventions to improve the adherence 
(20-24). No studies were found that objectively estimated 
non-adherence with other common chronic medications such 
as asthma, cholesterol, and diabetes among the homeless 
population. A major barrier in measuring medication 
adherence among homeless population can be the lack of 
patient records for the homeless. The purpose of this 
exploratory study was to objectively estimate the primary 
non-adherence and medication refill non-adherence to 
chronic medications among the homeless population in Salt 
Lake City (SLC), Utah based on pharmacy records from the 
Fourth Street Pharmacy. Utah has a homeless population of 
16,522 and has showed a 14% growth in homelessness from 
2005 to 2011 (25). The Fourth Street Pharmacy associated 




A retrospective study design was used based on the  
pharmacy records from the Fourth Street Pharmacy. The 
study only focused on a few widely-dispensed drugs from  
four classes of chronic medications: 1) asthma medications 
(Fluticasone/Salmeterol, Tiotropium,  
Budesonide/Formoterol, Albuterol/Ipratropium, and 
Beclomethasone); 2) diabetes medications (Insulin Glargine, 
Metformin, Glipizide Extended Release, and Insulin Lispro); 3) 
cholesterol lowering statins (Simvastatin and Atorvastatin); 
and 4) psychiatric medications (Buspirone, Risperisone, 
Olanzapine, Quetiapine, Escitalopram, Venlafaxine Extended 
Release, and Mirtazapine). The pharmacy obtains its 
medications through limited sources such as pharmaceutical 
company-sponsored patient assistance programs, Health 
Resources and Services Administration’s 340(b) program, and 
occasionally through wholesaler at market prices. Because of 
the way it procures its medications, not all medications are 
available in the pharmacy to be dispensed and the physicians 
in the clinic prescribe based on the available medications in 
the pharmacy. Thus, the above mentioned medications were 
chosen based on the pharmacy manager’s recommendations 
as few of the most widely dispensed medications from this 
pharmacy to the homeless population. Being an exploratory 
study, the goal was to estimate the rate of adherence with 
these commonly prescribed medications among the 
homeless. 
 
All the pharmacy records for the abovementioned 
medications between November 1, 2010 and February 28, 
2011 were reviewed. The four-month period was chosen 
 
since the homeless population move quite frequently. These 
months were selected based on the fact that before the 
winter sets into SLC by November, the homeless people who 
want to avoid the cold weather might have already moved 
out. If they are still in SLC in November, they may be planning 
to stay here for the remainder of the winter season. Table 1 
demonstrates the data collection table used for the study 
from the patient’s pharmacy records. The Institutional Review 
Board Approval was received from the investigator’s 
university. 
 
Primary non-adherence happens when patient fails to fill a 
new prescription. For this study, primary non-adherence was 
calculated as picking up the medicine more than 30 days after 
the original prescription was written. The prescriptions that 
were not refillable were excluded from the further analyses 
of medication refill non-adherence. Medication refill non- 
adherence was calculated using the Continuous Measure of 
Medication Gaps (CMG). CMG is the total number of days for 
which a medication is unavailable within a specific period. 
CMG is calculated by dividing the days of treatment gaps by 
number of days of study participation (26). The days of 
treatment gaps is obtained by subtracting the days supplied 
from the days in the study period. The study period was 
calculated for each patient depending on the number of  
refills and the number of days supplied. For example, a 
patient with 2 refills and 30 days’ supply of medicine each 
time will have a study period of 90 days (original fill of 30  
days plus 2 refills). When compared with medication 
possession ratio (MPR) and proportion of days covered (PDC), 
CMG is a better measure of medication refill non-adherence 
since it takes into account the early oversupply that will fill a 
later gap between refills (27). In addition, it does not allow an 
early gap between refills to be accounted for by later 
stockpiling. A CMG value of zero reflects complete adherence 
and one reflects complete non-adherence. For this study, a 
patient with a CMG value less than 20% was defined as 
adherent based on earlier studies (27, 28). 
 
Results 
Table 2 demonstrates the non-adherence and the confidence 
interval of the estimated non-adherence among the various 
medications in the four drug classes in detail. 
 
Asthma medications: There were 155 records; the average 
age of the patient was 49.55 ± 8.74 years; 72% were males; 
and 85% were white. The primary non-adherence rate was 
4.5% and based on the 20% cut-off value of CMG, the 
medication refill non-adherence rate with asthma 
medications was 38.8%. 
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Diabetes medications: There were 287 records for diabetes 
medications. The average age was 48.91 ± 9.93 years; 71% 
were males; and 80% were white. The primary non- 
adherence rate with diabetes medications was 12.9%, and 
the medication refill non-adherence rate was 38.5%. 
 
Statins: There were 125 records; the average age was 51.58 ± 
7.90; 78% were males; and 84% were white. While the 
primary non-adherence rate was 6.4%, the refill non- 
adherence rate was 27.2%. 
 
Psychiatric medications: There were 143 records. The average 
age was 43.38 ± 9.40, 58% were males, and 75% were white. 
The primary non-adherence rate was 2% and the refill non- 
adherence rate was 47.1%. 
 
Discussion 
This study was able to objectively estimate the extent of 
medication non-adherence in the homeless population in SLC 
with certain classes of medications in chronic conditions such 
as asthma, diabetes, cholesterol, and psychiatric problems. 
The results from this study demonstrated that primary non- 
adherence was low among the homeless population in SLC. 
With medication refill non-adherence, the non-adherence 
was highest with psychiatric medication and least with 
statins. 
 
Previous studies in asthma medications in general population 
demonstrated that the primary non-adherence rate with 
asthma medications range from 6 to 44% and the secondary 
non-adherence rates were more than 60% (4, 29). A study 
that measured the non-adherence rate in difficult to control 
asthma in general population found it to be 45% (30). A 
recent study, again in general population, showed that the 
adherence with beclomethasone was 50% by one year after 
treatment initiation (31). In the current study among 
homeless, the medication refill non-adherence was 50% with 
beclomethasone and albuterol/ipratropium, and ranged from 
28% to 43% for the other asthma medications. As can be 
seen, the medication non-adherence of the homeless with 
asthma medications were less than or similar to that of the 
general population. A possible reason for the lower/similar 
non-adherence rate with asthma medications in this 
population can be the symptomatic nature of the asthma 
disease condition and the increased severity of the condition 
during the winter months possibly due to the exposure to 
asthma triggering factors such as smog and viral 
exacerbations(32, 33). The data for this study was collected 
during the winter months. Since the data was only collected 
from the pharmacy records, the health status or illness 
severity of this specific population is not known. However, 
the public health records from Utah show that there were 
approximately 1600 hospitalizations due to asthma in 2011 in 
Salt Lake Valley (34). The age adjusted hospitalization rate for 
asthma in Salt Lake is approximately 5.5 per 10,000 and is 
higher than the state rate (34). Thus there is a possibility that 
these patients are sicker and hence demonstrating better 
adherence. 
 
The medication refill non-adherence with oral diabetes 
medications in this study was 27% for metformin and 39% for 
glipizide extended-release. This is similar to the studies done 
in general population where the non-adherence rate with  
oral hypoglycemic agents in insured population was between 
20 and 30% (35). The medication refill non-adherence to 
insulin therapy among low-income patients in general 
population was 41% (36). Compared to that, the non- 
adherence rate with Insulin Glargine was 43% and with   
Insulin Lispro was 67% among the homeless population in this 
study. Insulin injections need to be refrigerated and this  
might be the reason for the higher non-adherence rates with 
insulin injections compared to oral diabetes medications. In 
addition, the multiple dosing regimen of Insulin Lispro 
compared to the single dosing regimen of Insulin Glargine can 
possibly explain the comparatively higher non-adherence rate 
with Insulin Lispro (37, 38). A study conducted in Canada 
about diabetes management among homeless people 
reported inability to obtain insulin and other diabetic supplies 
when needed and the inability to coordinate medication with 
meals as the leading causes for medication non- 
adherence(39). 
 
Non-adherence to statins among the homeless population in 
this study was 21 and 29% for simvastatin and atorvastatin 
respectively. This is similar to the earlier studies in general 
population, where non-adherence to statins (taking less than 
80% of the prescribed medication assessed at 180 days) 
based on a literature review was 26% (40). Non-adherence 
with statins among non-Medicaid managed care organization 
enrollees was approximately 21% (41). 
 
A study carried out in general population in Canada has 
determined that the non-adherence rate was 34.6% for 
antipsychotics, 34.7% for sedative-hypnotics, 38.1% for 
anxiolytics, 44.9% for mood stabilizers and 45.9% for 
antidepressants (42). In the current study, buspirone which is 
prescribed as an anxiolytic has a similar non-adherence rate 
at 40%. The non-adherence rate with venlafaxine (used as an 
antidepressant in this population) was 30% and that with 
mirtazapine (used as a sleep-aid in this population) was 23%. 
It can be noted that these rates are lower than that of the 
non-adherence rates with these medications in general 
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population. However, the non-adherence rates were higher 
with drugs used in schizophrenia such as risperidone, 
olanzapine, and quetiapine at around 70%. Medication 
adherence is a challenge for patients with schizophrenia and 
a literature review on medication adherence with 
schizophrenic patients showed it at 50% (43). The higher rate 
of non-adherence with schizophrenic medications among the 
homeless patients in this study can be attributed to the 
unavailability of the drug in two different ways for this 
population at this pharmacy. Compared to the other 
psychiatric drugs, schizophrenic drugs were usually provided 
only for a week or two weeks due to the need to adjust the 
drug dosage based on each patient’s response to the drug. 
This can lead to non-adherence as the patient needs to come 
back to the pharmacy more often in the winter weather. In 
addition, if the patients start feeling better after taking the 
drug for few days they may have the tendency to discontinue 
the drug. In addition, these drugs were only available as 
brand drugs in the pharmacy; thus sometimes limiting the 
availability of the drug on a long term basis. 
 
As can be seen from the published literature, when compared 
to the rates in general population, the medication refill non- 
adherence rate was lower in asthma medications and similar 
in cholesterol medications. There can be several reasons for 
the low or comparable adherence rates with this population. 
The first and major reason can be the zero cost for 
medications for the homeless patient. As noted from the 
literature, cost of medications and unavailability of 
medications are few of the important barriers for medication 
adherence among the homeless (13, 23, 39, 46). All the 
medicines are provided free of cost from the Fourth Street 
Pharmacy. In addition, the physical location of the clinic and 
the pharmacy in the center of the town makes it easier for  
the homeless to access them without difficulty. This may at 
least explain the low rates of primary non-adherence. Also, 
the low primary non-adherence can be another reason for 
improved refill adherence (22). Second, the pharmacy, with 
the help of the pharmacy manager and a staff pharmacist, 
teaches the patients to become accountable for their  
diseases and medications. Previous studies on medication 
adherence in homeless reported that communication issue 
was a major barrier for adherence in this population and thus 
educating homeless patients about the need for medication 
adherence and follow-up visits is considered as an important 
step in their treatment plan (16, 23, 45, 46). For asthma and 
diabetes medications, the Fourth Street Pharmacy patients 
are taught how to use the inhaler and the glucometer with 
special focus on the need of medication adherence. For 
diabetes patients, the pharmacist who is also a trained 
diabetes specialist provides intensive education sessions for 
the patient, which continues over time with ongoing follow- 
up between the patient and the pharmacy staff. As 
appropriate, the pharmacist again meets one-on-one with the 
patient to review therapeutic goals and outcomes. For 
psychiatric conditions, patients are provided regular 
counseling by a prescribing psychiatric nurse, again with 
emphasis on medication adherence. Third, there is a human 
element that might be improving the medication adherence  
in this population. The staff at the Fourth Street Clinic and 
Pharmacy provides a sense of warmth and belonging to these 
patients while they are at the clinic or pharmacy; the patient 
population itself fosters an independent culture where 
patients feel comfortable. This may prompt the homeless to 
visit the pharmacy on a regular basis and fill their  
medications. Social support is a major factor in improving 
medication adherence (47-50). For this specific homeless 
population, it is not possible to determine whether they are 
transiently or permanently homeless. Thus, the assumption 
that the social support from the pharmacy staff might be one 
of the reasons for improved medication adherence. 
 
The significantly higher medication refill non-adherence rate 
for this population compared to the primary non-adherence 
can be due to any reasons for non-adherence such as illness 
and/or medication beliefs of the patient, slow response to   
the symptoms, or discontinuing medications when feeling 
better or worse. It may also be that these patients might have 
moved away or are not homeless anymore. However, future 
studies should be carried out to understand the reasons for 
higher refill non-adherence so that effective intervention 
strategies can be developed. Also, the comparatively higher 
non-adherence rate with psychiatric medications can be a 
cause of concern as this may lead to suboptimal clinical 
outcomes for patients with mental illnesses. Mental illness is 
one of the predictors for homelessness and patients with 
schizophrenia and bipolar disorders have higher odds of   
being homeless compared to other psychiatric conditions  
(51). Thus, the higher non-adherence with psychiatric 
medications, especially with medications for schizophrenia as 
seen from this study can create a cycle that will be difficult to 
break, thereby increasing the health care costs of the society. 
 
Measuring the medication adherence among the homeless is 
important as this can be a major key in reducing the overall 
health care costs by avoiding emergency room and hospital 
admissions that can result from uncontrolled chronic 
conditions. A Canadian study reported that 47% of the 156 
homeless men studied had been to the emergency room in 
the previous year and 24% got admitted to the hospital 
overnight or longer(44). This exploratory study is a step 
towards understanding the medication adherence of the 
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homeless with chronic medications. Further studies need to 
be conducted to understand the reasons for not adhering  
with medications especially with certain psychiatric 
medication to develop appropriate intervention strategies for 
the homeless. Qualitative analyses such as in-depth  
interviews with these individuals, observing the 
communication between these individuals and the health  
care providers, can provide significant input into the barriers 
for refill adherence among this population. In addition, linking 
the adherence measures with the clinical outcomes can be 
another way of validating these results. 
 
Limitations of the study: 
The study is not without limitations. First, the study is a 
retrospective data analysis based on refill records from the 
pharmacy. As with any other adherence retrospective study, 
though patients filled the prescription, the actual 
consumption of the medicines is not known. Perhaps 
another study linking the pharmacy records with the 
medical charts may give more insight into the actual clinical 
outcome of the homeless patients. It is also to be kept in 
mind that these are homeless patients and those who did 
not obtain the refills might have moved away or who 
became eligible to fill prescriptions through Medicaid. 
Second, the analysis is limited to four months from 
November 2010 to February 2011. Thus, generalizing the 
results from this study has to be done cautiously. The 
patients approaching the pharmacy during these winter 
months as well as the health conditions of these individuals 
may be different from the homeless individuals during the 
other months. The winters in SLC has average temperatures 
ranging from 20 to 45 degrees Fahrenheit. Thus, the 
homeless staying in SLC for the winter may be healthier 
than those who move out of city during the winter months. 
Third, the Fourth Street Pharmacy cannot be considered as 
a representative pharmacy for the homeless, thus further 
limiting the generalizability of the study. 
However, there are no other pharmacies in SLC that 
exclusively provides to the uninsured homeless population. 
Fourth, there is a possibility of underestimation of 
adherence since the analysis of CMG also included patient 
records that never made any refills. Studies have shown 
that excluding those records that exhibit early non-
persistence (no refills) can overestimate adherence by 9 to 
18% (52). Thus, it was decided to include those records for a 
more conservative approach in analyzing the data. Finally, it 
is also to be kept in mind that being an exploratory study, 
the data available was limited and hence only limited 
analysis were carried out. 
Unlike a conventional pharmacy, the Fourth Street Pharmacy 
only carters to uninsured homeless population and has 
different operation system. Also, the study did not collect any 
data on the actual clinical outcomes. Thus, it is not possible to 
determine whether the adherence rates actually converted 
to clinical outcomes. 
 
Conclusions 
The aim of this exploratory study was to estimate the 
extent of medication non-adherence among the homeless  
population in Salt Lake City for certain medications in four 
chronic illnesses including asthma, diabetes, cholesterol, 
and psychiatric problems. The study concluded that this 
population has comparable rates of non-adherence with 
certain medications in the classes of asthma, diabetes, 
cholesterol, and psychiatric conditions compared to the 
general population. Further studies are needed to 
understand the actual behavior of medicine consumption 
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Table 1: Data Collected for the Calculation of Medication Refill Adherence 
 
Data collected: Drugs studied: 
Drug Class Fluticasone/Salmeterol 




Date of original prescription Insulin Glargine 
Number of refills on the original prescription Metformin 
Date of first/original fill of the prescription Glipizide Extended Release 
Number filled Insulin Lispro 
Number of days supplied based on the dosage Simvastatin 
Date of first refill Atorvastatin 
Date of second refill Buspirone 
Date of third refill Risperidone 
Date of fourth refill Olanzapine 
Date of fifth refill Quetiapine 
 Escitalopram 
 Venlafaxine Extended Release 
 Mirtazapine 
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Table 2: Non-adherence for each selected medication in the four chronic 
medication drug classes among the homeless population in Salt Lake City, Utah 


















– N (%) 
95% confidence 





Fluticasone/Salmeterol (39) 2 (5%) (-1.84, 11.84)% 5 34 12 (35.3%) (20.3, 50.3)% 
Tiotropium (48) 1 (2%) (-1.96, 5.96)% 5 43 12 (27.9%) (15.21, 40.59)% 
Budesonide/Formoterol (11) 2 (18%) (-4.7, 40.7)% 4 7 3 (42.9%) (13.65, 72.15)% 
Albuterol/Ipratropium (6) 0 (0%) (0, 0)% 0 6 3 (50%) (9.99, 90.01)% 
Beclamethasone (51) 2 (4%) (-1.38, 9.38)% 12 39 20 (51.3%) (37.58, 65.02)% 
N = 155 7 (4.5%) (1.24, 7.76)% 26 129 50 (38.8%) (31.13, 46.47)% 
Diabetes 
Insulin Glargine (60) 8 (13.3%) (4.71, 21.89)% 6 54 23 (42.6%) (30.09, 55.11)% 
Metformin (137) 16 (11.6%) (6.24, 16.96)% 13 124 33 (26.6%) (19.2, 34)% 
Glipizide Extended Release (44) 4 (9%) (0.54, 17.46)% 3 41 16 (39%) (24.59, 53.41)% 
Insulin Lispro (46) 9 (19.6%) (8.13, 31.07)% 3 43 29 (67.4%) (53.85, 80.95)% 
N = 287 37 (12.9%) (9.02, 16.78)% 25 262 101 (38.5%) (32.87, 44.13)% 
Cholesterol 
Simvastatin (48) 5 (10.4%) (1.76, 19.04)% 7 41 10 (20.8%) (9.32, 32.28)% 
Atorvastatin (77) 3 (3.8%) (-0.47, 8.07)% 4 73 21 (28.8%) (18.69, 38.91)% 
N = 125 8 (6.4%) (2.11, 10.69)% 11 114 31 (27.2%) (19.4, 35)% 
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Buspirone (11) 1 (9%) (-7.91, 25.91)% 1 10 4 (40%) (11.05, 68.95)% 
Risperidone (38) 0 (0%) (0, 0)% 9 29 18 (62%) (46.57, 77.43)% 
Olanzapine (12) 0 (0%) (0, 0)% 3 9 7 (77.8%) (54.29, 
101.31)% 
Quetiapine (25) 0 (0%) (0, 0)% 5 20 14 (70%) (52.04, 87.96)% 
Escitalopram (4) 0 (0%) (0, 0)% 1 3 1 (33.3%) (-12.89, 
79.49)% 
Venlafaxine Extended Release (18) 1 (5.5%) (-5.03, 16.03)% 1 17 5 (29.4%) (8.35, 50.45)% 
Mirtazapine (35) 1(2.9%) (-2.66, 8.46)% 4 31 7 (22.6%) (8.74, 36.46)% 
N = 143 3 (2%) (-0.29, 4.29)% 24 119 56 (47.1%) (38.92, 55.28)% 
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